Order for pharmaceutical strensiq 80MG

Ended Awarded Last action

Contract number
36C26024F0096
Awardee
Awarding agency
Obligated
$522,487

Award facts

Contract value 100% obligated
$522,487.40 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Boston, MA 02210, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 -$126,279
Other Administrative Action P00002 -$605,203
Other Administrative Action P00001 $126,279
Original award $1,127,691

About this award

The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order to Alexion Pharmaceuticals Inc., a foreign-owned, for-profit biopharmaceutical company, to provide the pharmaceutical drug Strensiq 80mg. The contract, valued at $522,487.40, was awarded under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) and does not have a set-aside designation. Alexion will perform the contract in Boston, Massachusetts, delivering Strensiq, which is used to treat the rare genetic disorder perinatal/infantile- and juvenile-onset hypophosphatasia. This Delivery Order is part of a larger Blanket Purchase Agreement (BPA) Alexion holds with the VA National Acquisition Center, valued at up to $4,239,517.80, that allows VA medical centers nationwide to efficiently procure Strensiq to ensure continuity of care for affected patients.

Quick answers

Who was awarded contract 36C26024F0096?

36C26024F0096 was awarded to Alexion Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 22, 2023.

How much is contract 36C26024F0096 worth?

The government has obligated $522,487 on 36C26024F0096.

Is contract 36C26024F0096 an order under another contract?

Yes. 36C26024F0096 is a delivery order under 36F79718D0355, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26024F0096 competed?

The extent of competition for 36C26024F0096 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award